Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Considerations for PIK3CA mutations: An interactive discussion (ID 738)

Lecture Time
12:35 - 12:50
Speakers
  • Nicholas C. Turner (London, United Kingdom)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00